Biocodex is a multinational pharmaceutical company with a strong focus on healthcare solutions worldwide. With 16 subsidiaries and over 100 partners, they are committed to providing effective and innovative treatments for microbiota care, women's health, and orphan diseases. As pioneers in gut microbiota research, Biocodex aims to become the global leader in microbiota care, while also supporting women's health at every stage of their lives and developing drugs for patients with severe orphan diseases.
Rooted in a 70-year heritage as the marketer of the world's first probiotic yeast strain, Biocodex has evolved into an international player in the microbiota realm. With a responsible attitude towards the environment and society, they strive to bring quality products, expert advice, and sustainable choices to improve health worldwide. With a dedicated team of 1600 employees and a revenue of 501 million in 2022, Biocodex continues to grow while remaining agile and true to their values.
Generated from the website